Names provide memory cues, and sales rely on this association whether the product is the same as what you remember it to be or not. This discrepancy is particularly problematic when it comes to marijuana, also known as weed, pot, dope, reefer or more formally, cannabis.
The problem is that the THC (tetrahydrocannabinol) content in marijuana products is not the same as it was decades ago. In fact, it has routinely risen to well over 50 percent in edibles, wax, vapes or dabs (butane hash oil). So even if your memory flashes you back to something you first learned about or tried in high school, in fact, what you encounter now is not the same.
A recent review of 20 studies in the medical journal Lancet reveals that high potency THC products lead to a much higher rate of addiction (regular or daily use), cannabis use disorder, which in turn is associated with a much higher rate of cannabis-induced psychosis. This condition, characterized by hallucinations and delusions, may last for one to two days but if the person happens to have an underlying psychiatric disorder (such as schizophrenia), which might not be known at the time, It can last months or even longer.
The problem with the current push toward legalization is that it doesn’t include efforts to limit the percentage of THC in the product. I think Italy has it right. Cannabis is not strictly legal there, but it is decriminalized, and shops there can and do sell cannabis products with up to 0.5 percent THC, a much safer percentage. These shops are busy, and one could argue that they are diverting users away from the higher potency, more dangerous products. This is a strategy that should be considered here.
To Read The Rest Of This Article By Dr. Marc Siegel on The Hill
Published: September 08, 2022
Founder & Interim Editor of L.A. Cannabis News